These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 8516290)

  • 41. Identification of 40 genes on a 1-Mb contig around the IL-4 cytokine family gene cluster on mouse chromosome 11.
    Wenderfer SE; Slack JP; McCluskey TS; Monaco JJ
    Genomics; 2000 Feb; 63(3):354-73. PubMed ID: 10704283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
    Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
    Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Parallel loss of c-FMS and GM-CSF genes in myeloid leukemias with 5q-chromosome].
    Tanaka K; Takechi M; Shigeta C; Oguma N; Kamada N; Takimoto Y; Kuramoto A; Kyo T; Dohy H
    Rinsho Ketsueki; 1991 Sep; 32(9):931-7. PubMed ID: 1942539
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fluorescence in situ hybridization confirmation of 5q deletions in patients with hematological malignancies.
    Brezinová J; Zemanová Z; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2000 Feb; 117(1):45-9. PubMed ID: 10700866
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular genetics of myeloid leukemia: identification of the commonly deleted segment of chromosome 20.
    Roulston D; Espinosa R; Stoffel M; Bell GI; Le Beau MM
    Blood; 1993 Dec; 82(11):3424-9. PubMed ID: 8241509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of chromosome 5 aberrations in complex karyotypes of patients with myeloid disorders reveals their contribution to dicentric and tricentric chromosomes, resulting in the loss of critical 5q regions.
    Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; Morice P; Abgrall JF; Berthou C; De Braekeleer M
    Cancer Genet Cytogenet; 2007 Jun; 175(2):125-31. PubMed ID: 17556068
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31.
    Horrigan SK; Arbieva ZH; Xie HY; Kravarusic J; Fulton NC; Naik H; Le TT; Westbrook CA
    Blood; 2000 Apr; 95(7):2372-7. PubMed ID: 10733509
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.
    Douet-Guilbert N; Basinko A; Morel F; Le Bris MJ; Ugo V; Morice P; Berthou C; De Braekeleer M
    Ann Hematol; 2008 Jul; 87(7):537-44. PubMed ID: 18350294
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Refinement of the commonly deleted segment in myeloid leukemias with a del(20q).
    Wang PW; Iannantuoni K; Davis EM; Espinosa R; Stoffel M; Le Beau MM
    Genes Chromosomes Cancer; 1998 Feb; 21(2):75-81. PubMed ID: 9491317
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Three rearrangements of chromosome 5 in a patient with myelodysplastic syndrome: an atypical deletion 5q, a complex intrachromosomal rearrangement of chromosome 5, and a paracentric inversion of chromosome 5.
    Douet-Guilbert N; Basinko A; Eveillard JR; Morel F; Le Bris MJ; Guéganic N; Bovo C; Herry A; Berthou C; De Braekeleer M
    Cancer Genet Cytogenet; 2010 Dec; 203(2):303-8. PubMed ID: 21156249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multilineage involvement in the 5q- syndrome: a fluorescent in situ hybridization study on bone marrow smears.
    Bigoni R; Cuneo A; Milani R; Cavazzini F; Bardi A; Roberti MG; Agostini P; della Porta M; Specchia G; Rigolin GM; Castoldi G
    Haematologica; 2001 Apr; 86(4):375-81. PubMed ID: 11325642
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia.
    Trost D; Hildebrandt B; Beier M; Müller N; Germing U; Royer-Pokora B
    Cancer Genet Cytogenet; 2006 Feb; 165(1):51-63. PubMed ID: 16490597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: retention of IRF1 on the 5q- chromosome in some patients with the 5q- syndrome.
    Boultwood J; Fidler C; Lewis S; MacCarthy A; Sheridan H; Kelly S; Oscier D; Buckle VJ; Wainscoat JS
    Blood; 1993 Nov; 82(9):2611-6. PubMed ID: 8219215
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interleukin-5 is at 5q31 and is deleted in the 5q- syndrome.
    Sutherland GR; Baker E; Callen DF; Campbell HD; Young IG; Sanderson CJ; Garson OM; Lopez AF; Vadas MA
    Blood; 1988 Apr; 71(4):1150-2. PubMed ID: 3258537
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular analysis of the 5q- chromosome.
    Nagarajan L
    Leuk Lymphoma; 1995 May; 17(5-6):361-6. PubMed ID: 7549826
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assignment of CSF-1 to 5q33.1: evidence for clustering of genes regulating hematopoiesis and for their involvement in the deletion of the long arm of chromosome 5 in myeloid disorders.
    Pettenati MJ; Le Beau MM; Lemons RS; Shima EA; Kawasaki ES; Larson RA; Sherr CJ; Diaz MO; Rowley JD
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2970-4. PubMed ID: 3495006
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Linkage mapping of the human CSF2 and IL3 genes.
    Frolova EI; Dolganov GM; Mazo IA; Smirnov DV; Copeland P; Stewart C; O'Brien SJ; Dean M
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4821-4. PubMed ID: 1675789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Pavlistová L; Babická L; Housková L; Melichercíková J; Sisková M; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2007 Feb; 173(1):10-6. PubMed ID: 17284364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Somatic cell hybrid mapping of human chromosome band 5q31: a region important to hematopoiesis.
    Neuman WL; Le Beau MM; Farber RA; Lindgren V; Westbrook CA
    Cytogenet Cell Genet; 1992; 61(2):103-6. PubMed ID: 1395713
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients.
    Pellagatti A; Jädersten M; Forsblom AM; Cattan H; Christensson B; Emanuelsson EK; Merup M; Nilsson L; Samuelsson J; Sander B; Wainscoat JS; Boultwood J; Hellström-Lindberg E
    Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11406-11. PubMed ID: 17576924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.